Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients experience treatment failure and most of them are typically treated with salvage chemotherapy and autologous stem cell transplantation (autoSCT). However, 45–55% of that subset further relapse or progress despite in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilakopoulos, Theodoros P., Chatzidimitriou, Chrysovalantou, Asimakopoulos, John V., Arapaki, Maria, Tzoras, Evangelos, Angelopoulou, Maria K., Konstantopoulos, Kostas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721364/
https://www.ncbi.nlm.nih.gov/pubmed/31362369
http://dx.doi.org/10.3390/cancers11081071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721364/
https://www.ncbi.nlm.nih.gov/pubmed/31362369
http://dx.doi.org/10.3390/cancers11081071

Ejemplares similares